|
Neurodegenerative disorders and their treatment 6th
June 2007 |
|
| Programme: | |
| 09.30 | Registration and Coffee |
| Session 1. Chair: Eric Karran, Lilly | |
| 10.00 |
Jill Richardson, GlaxoSmithKline Overview of neurodegenerative disorders, mechanisms of cell death and approaches to treatment |
| 10.40 |
Dr Roger Bullock, Kingshill Research
Centre Current therapies for Alzheimer’s Disease |
| 11.20 |
Dr Lit-Fui Lau, Pfizer Global
Research, USA The prospects for modifying the course of Alzheimer’s dementia |
| 12.00 |
Prof Alan Crossman, University of
Manchester Pharmacologicial approaches to the treatment of Parkinson’s disease |
| 12.40 | Lunch |
| Session 2. Chair: Stephen Mitchell | |
| 13.40 |
Dr Steve Dunnett, Cardiff University Cellular and regenerative approaches to the treatment of Parkinson’s disease |
| 14.20 |
Dr Michael O'Neill, Lilly Treatment prospects for stroke |
| 15.00 | Tea |
| Session 3. Chair: Alan Palmer, Pharmidex | |
| 15.30 |
Prof Ed Dixon, University of Pittsburgh,
USA Treatment prospects for traumatic brain injury |
| 16.10 |
Prof Ken Smith, Kings College Preventing axonal degeneration in multiple sclerosis |
| 16.50 | Close |
| Home / Meetings / Membership / Student Bursaries / Administration / History of the SMR / SMR Award / Archive Material / Links / Contact Us |